2019 Graduate

Jake Amerine

  • Initial/Current Employment:
  • Relevant Publications: Amerine J, Oertel M, Odinet J, Pappas A. Financial impact of drug shortages at an academic medical center. Poster session presented at: ASHP Summer Meeting; 2019 June 10; Boston, MA.

2018 Graduate

Johlee Odinet

  • Initial/Current Employment: Medication Safety Officer, Ochsner Medical Center, Baton Rouge, LA
  • Relevant Publications/Presentations: 
    • Fortenberry M, Odinet J, Faircloth C, McKinzie C, Falato C, Pappas A, Murphy K. Development of an Electronic Trigger Tool at a Children’s Hospital within an Academic Medical Center. American Journal of Health-System Pharmacy.  In press.
    • Cass AS, Odinet JS, Valgus JM, Crona DJ. Infusion reactions following administration of intravenous rolapitant at an academic medical center. J Oncol Pharm Pract. 2019 Oct;25(7):1776-1783.
    • Odinet JS, Day CE, Cruz JL, Heindel GA. The Biosimilar Nocebo Effect? A Systematic Review of Double-Blinded Versus Open-Label Studies. J Manag Care Spec Pharm. 2018 Oct;24(10):952-959.
    • Odinet J, Fortenberry M, Shah P, Pappas A, Murphy K. Development of an electronic trigger tool at a children’s hospital within an academic medical center. Poster session presented at: ASHP Summer Meeting; 2018 June 3; Denver, CO.

2017 Graduate

Pooja Shah

  • Initial Employment: Medication Strategy Specialist, Wake Forest Baptist Health, Winston-Salem, NC
  • Current Employment: Clinical Specialist, Medication Utilization Management, UNC Health Care, Chapel Hill, NC
  • Relevant Publications: Shah PJ, Cruz JL, Pappas AL, Waldron KM, Savage SW. Impact of Inpatient Automatic Therapeutic Substitutions on Postdischarge Medication Prescribing. Hosp Pharm. 2017 Oct;52(9):635-639.

2016 Graduate

Gregory Heindel

  • Initial Employment: Drug Information Specialist, Intermountain Healthcare, Salt Lake City, UT
  • Current Employment:Clinical Specialist, Drug Information and Policy, UNC Health Care, Chapel Hill, NC
  • Relevant Publications:
    • Heindel GA. Utilizing drug information centers for local coverage determination reconsiderations. Platform session presented at: Innovations and Research in Drug Information: ASHP Midyear Clinical Meeting; 2016 Dec 4-8; Las Vegas, NV.
    • Heindel GA, Stivers AP. Culture Changes Needed to Implement ISMP IV Push Guidelines. Hosp Pharm. 2017 Mar;52(3):167-168.
    • Heindel G, Smith J, Cruz J, Pappas A. Utilizing a drug information center for submitting reconsiderations for local coverage determinations. Am J Health Syst Pharm. 2017 Feb 1;74(3):106-107. 
    • Heindel GA, Morbitzer K, Stivers A. Clinical effects of the addition of strong CYP3A4 inhibitors to continuous intravenous infusion fentanyl. Poster session presented at: ASHP Summer Meeting; 2016 June 13; Baltimore, MD.

For more information contact:

Kamakshi Rao

Kamakshi Rao, PharmD, BCOP, CPP, FASHP
Assistant Director for Education, Research, and Practice Training